Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate |
N-[4,6-二氨基-2-[1-[(2-氟苯基)甲基]-1H-吡唑并[3,4-B]吡啶-3-基]-5-嘧啶]-氨基甲酸甲酯 |
625115-52-8 |
N,N'-((5-methylisoxazole-3,4-diyl)bis(4,1-phenylenesulfonyl)) dipropionamide |
N,N'-((5-甲基异恶唑-3,4-二基)双(4,1-苯磺酰基))二丙酰胺 |
2251048-76-5 |
(S)-1-(naphthalen-1-yl)-N-(3-(trifluoromethyl)benzyl)ethan-1-amine |
西那卡塞杂质22 |
2518010-91-6 |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
PALBOCICLIB杂质B |
1651214-74-2 |
diisopropyl 2,2'-((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(azanediyl))(2S,2'S)-dipropionate compound with methane (1:1) |
替诺福韦拉酚氨酯杂质01 |
1883563-86-7 |
Benzyl (4-broMo-3-fluorophenyl)carbaMate |
N-苄氧羰基-4-溴-3-氟苯胺 |
510729-01-8 |
(S)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)thiophene-2-carboxaMide |
(S)-4,5-二氯-N-((2-氧代-3-(4-(3-氧代吗啉代)苯基)噁唑烷-5-基)甲基)噻吩-2-甲酰胺 |
1770812-37-7 |
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- |
3 - ((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶- |
1675248-18-6 |
Azilsartan Impurity |
Azilsartan Impurity |
1821386-21-3 |
Valdecoxib IMpurity F |
4-(5-甲基-3-苯基-4-异恶唑)苯磺酰氯 |
509074-26-4 |
2,4,5-Trifluorobenzaldehyde |
2,4,5-三氟苯甲醛 |
165047-24-5 |
3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL |
3-(3-三氟甲基苯基)丙醇 |
78573-45-2 |
TAK-438 |
富马酸沃诺拉赞 |
1260141-27-2 |
(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone |
匹多莫德 杂质 |
14842-41-2 |
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine |
(3S,4S)-1-苄基-N,4-二甲基哌啶-3-胺 |
1354486-07-9 |
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid |
(2S)-2-(2-氧代吡咯烷-1-基)丁酸 |
102849-49-0 |
(S)-Tenofovir |
S-替诺福韦 |
147127-19-3 |
(S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide |
左乙拉西坦相关物质A |
102767-31-7 |
(S)-Duloxetine SuccinaMide |
度洛西汀相关物质H |
199191-66-7 |
(S)-4-Desmethoxy-4-chloro Omeprazole |
(S)-4-去甲氧基-4-氯奥美拉唑 |
863029-89-4 |